CLASS II Device recall · Reported 26 Feb 2020 · FDA Enforcement Report

Dimension Vista Enzymatic Creatinine (Ecrea) reagent, SMN recalled

Siemens Healthcare Diagnostics is recalling Dimension Vista Enzymatic Creatinine (Ecrea) reagent, SMN 10700444, distributed nationwide in the US. The recall was initiated on 18 Dec 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI Number: 00842768036262 Lots: All lots
Quantity recalled11,725 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1233-2020
FDA event ID
84612
Recalling firm
Siemens Healthcare Diagnostics, Tarrytown, NY
Classification
Class II
Status
Terminated
Recall initiated
18 Dec 2019
FDA classified
14 Feb 2020
Reported
26 Feb 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

18 Dec 2019Recall initiated by company
14 Feb 2020Classified by FDA+58 days
26 Feb 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.

Product as listed by the FDA

Dimension Vista Enzymatic Creatinine (ECREA) reagent, SMN 10700444

Where it was distributed

US Nationwide

Nationwide

Questions about this recall

Why was it recalled?

There is a potential for falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology. Interference has not been observed with the creatinine Jaffe methodology.

Which lots are affected?

UDI Number: 00842768036262 Lots: All lots

Where was it sold?

US Nationwide

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 84612

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656